Spermidine in dementia : Relation to age and memory performance
- PMID: 31832773
- PMCID: PMC6978435
- DOI: 10.1007/s00508-019-01588-7
Spermidine in dementia : Relation to age and memory performance
Abstract
Previous studies have highlighted that spermidine has the ability to trigger the important process of dissolving amyloid-beta plaques by autophagy. This manuscript focuses on the correlation of serum spermidine levels between age and between performance in mini-mental state examinations. It will serve as a premise for an ongoing multicentric placebo-controlled study, which focuses on the effect of oral spermidine supplementation on memory performance. Memory tests were carried out on 80 subjects aged 60-96 years old in 6 nursing homes in Styria. Blood samples were taken for the determination of spermidine concentration. The results showed a significant correlation between the spermidine concentration and the mini-mental state examination score (p = 0.025). On the basis of the dependence demonstrated it can be concluded that spermidine might be suitable as a biomarker for the diagnosis of neurocognitive changes (senile dementia or Alzheimer's disease).
Keywords: Alzheimer’s disease; CERAD Plus; Dementia; Memory performance; Spermidine.
Conflict of interest statement
T. Pekar, A. Wendzel, W. Flak, A. Kremer, S. Pauschenwein-Frantsich, A. Gschaider, F. Wantke, and R. Jarisch declare that they have no competing interests.
Figures



Comment in
-
Statistically significant but clinically irrelevant correlation?Wien Klin Wochenschr. 2020 Sep;132(17-18):547-548. doi: 10.1007/s00508-020-01634-9. Epub 2020 Mar 18. Wien Klin Wochenschr. 2020. PMID: 32189118 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical